Home › Funds › Laurion Capital Management LP › PYXS

Laurion Capital Management LP position in PYXS

PYXIS ONCOLOGY INC · Health Care

Laurion Capital Management LP reported holding 4,989,888 shares of PYXS (PYXIS ONCOLOGY INC) in its Q3 2026 13F filing — a position valued at US$11.6M, representing 0.63% of its reported portfolio and ranking #38 among its reported holdings. Laurion Capital Management LP has disclosed PYXS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)4.99M sh
Reported value held$11.63M
Portfolio Weight0.63%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Laurion Capital Management LP's PYXS position evolved

Laurion Capital Management LP first disclosed a stake in PYXS in Q3 2023 at 3,170,803 shares (US$6.3M). The position peaked in Q1 2024 at 3,861,179 shares, worth US$16.4M. Across 13 filings, Laurion Capital Management LP increased the stake 4 time(s), trimmed it 2 time(s) and left it unchanged 6 time(s). The most recent filing (Q3 2026) shows 4,989,888 shares valued at US$11.6M — an increase of 89,000 shares quarter over quarter.. Notable position changes include a 32% increase in Q4 2025 (shares rose 27% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 3.17M $6.31M New
Q4 2023 3.17M $5.71M Hold
Q1 2024 3.86M $16.45M Add
Q2 2024 3.86M $12.78M Hold
Q3 2024 3.63M $13.31M Reduce
Q4 2024 3.63M $5.66M Hold
Q1 2025 3.63M $3.55M Hold
Q2 2025 3.63M $3.99M Hold
Q3 2025 3.63M $8.05M Hold
Q4 2025 4.80M $5.52M Add
Q1 2026 5.00M $7.30M Add
Q2 2026 4.90M $14.75M Reduce
Q3 2026 4.99M $11.63M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PYXS and 13F data

PYXS (PYXIS ONCOLOGY INC) is a Health Care company. 31 other funds we track also report a position in PYXS — the largest reported positions include GordonMD Global Investments LP (US$30.2M), PFIZER INC (US$20.1M), Palo Alto Investors LP (US$2.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PYXS

All PYXS fund holders →

FAQ

How long has Laurion Capital Management LP held PYXS?

Laurion Capital Management LP has disclosed PYXS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Laurion Capital Management LP's current position in PYXS?

As of Q3 2026, Laurion Capital Management LP holds 4.99M shares of PYXS (PYXIS ONCOLOGY INC), valued at $11.63M, representing 0.63% of its reported portfolio and ranking #38.

Has Laurion Capital Management LP been buying or selling PYXS?

In the latest 13F filing (Q3 2026), Laurion Capital Management LP increased its position in PYXS. The position peaked in Q1 2024 at 3.86M shares.

Which other funds hold PYXS?

Other major institutional holders of PYXS include GordonMD Global Investments LP, PFIZER INC, Palo Alto Investors LP, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.